Nektar Therapeutics Reveals Financial Performance and Market Updates for the Third Quarter of 2026

SAN FRANCISCO, Nov. 12, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced its financial results for the third quarter ended September 30, 2026, and provided a business update.